Report cover image

Global Riluzole Tablet Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 197 Pages
SKU # APRC20556939

Description

Summary

According to APO Research, the global Riluzole Tablet market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Riluzole Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Riluzole Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Riluzole Tablet market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Riluzole Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Riluzole Tablet market include Apotex, Covis Pharma, Glemark Generics, Italfarmaco, Lunan Pharma, Mylan Pharma, Sanofi and Sun Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Riluzole Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Riluzole Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Riluzole Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Riluzole Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Riluzole Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Riluzole Tablet sales, projected growth trends, production technology, application and end-user industry.

Riluzole Tablet Segment by Company

Apotex
Covis Pharma
Glemark Generics
Italfarmaco
Lunan Pharma
Mylan Pharma
Sanofi
Sun Pharma
Riluzole Tablet Segment by Type

With Film-coated
Without Film-coated
Riluzole Tablet Segment by Application

Hospital
Pharmacy
Riluzole Tablet Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Riluzole Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Riluzole Tablet market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Riluzole Tablet significant trends, drivers, influence factors in global and regions.
6. To analyze Riluzole Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Riluzole Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Riluzole Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Riluzole Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Riluzole Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Riluzole Tablet industry.
Chapter 3: Detailed analysis of Riluzole Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Riluzole Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Riluzole Tablet in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Riluzole Tablet Sales Value (2020-2031)
1.2.2 Global Riluzole Tablet Sales Volume (2020-2031)
1.2.3 Global Riluzole Tablet Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Riluzole Tablet Market Dynamics
2.1 Riluzole Tablet Industry Trends
2.2 Riluzole Tablet Industry Drivers
2.3 Riluzole Tablet Industry Opportunities and Challenges
2.4 Riluzole Tablet Industry Restraints
3 Riluzole Tablet Market by Company
3.1 Global Riluzole Tablet Company Revenue Ranking in 2024
3.2 Global Riluzole Tablet Revenue by Company (2020-2025)
3.3 Global Riluzole Tablet Sales Volume by Company (2020-2025)
3.4 Global Riluzole Tablet Average Price by Company (2020-2025)
3.5 Global Riluzole Tablet Company Ranking (2023-2025)
3.6 Global Riluzole Tablet Company Manufacturing Base and Headquarters
3.7 Global Riluzole Tablet Company Product Type and Application
3.8 Global Riluzole Tablet Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Riluzole Tablet Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Riluzole Tablet Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Riluzole Tablet Market by Type
4.1 Riluzole Tablet Type Introduction
4.1.1 With Film-coated
4.1.2 Without Film-coated
4.2 Global Riluzole Tablet Sales Volume by Type
4.2.1 Global Riluzole Tablet Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Riluzole Tablet Sales Volume by Type (2020-2031)
4.2.3 Global Riluzole Tablet Sales Volume Share by Type (2020-2031)
4.3 Global Riluzole Tablet Sales Value by Type
4.3.1 Global Riluzole Tablet Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Riluzole Tablet Sales Value by Type (2020-2031)
4.3.3 Global Riluzole Tablet Sales Value Share by Type (2020-2031)
5 Riluzole Tablet Market by Application
5.1 Riluzole Tablet Application Introduction
5.1.1 Hospital
5.1.2 Pharmacy
5.2 Global Riluzole Tablet Sales Volume by Application
5.2.1 Global Riluzole Tablet Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Riluzole Tablet Sales Volume by Application (2020-2031)
5.2.3 Global Riluzole Tablet Sales Volume Share by Application (2020-2031)
5.3 Global Riluzole Tablet Sales Value by Application
5.3.1 Global Riluzole Tablet Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Riluzole Tablet Sales Value by Application (2020-2031)
5.3.3 Global Riluzole Tablet Sales Value Share by Application (2020-2031)
6 Riluzole Tablet Regional Sales and Value Analysis
6.1 Global Riluzole Tablet Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Riluzole Tablet Sales by Region (2020-2031)
6.2.1 Global Riluzole Tablet Sales by Region: 2020-2025
6.2.2 Global Riluzole Tablet Sales by Region (2026-2031)
6.3 Global Riluzole Tablet Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Riluzole Tablet Sales Value by Region (2020-2031)
6.4.1 Global Riluzole Tablet Sales Value by Region: 2020-2025
6.4.2 Global Riluzole Tablet Sales Value by Region (2026-2031)
6.5 Global Riluzole Tablet Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Riluzole Tablet Sales Value (2020-2031)
6.6.2 North America Riluzole Tablet Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Riluzole Tablet Sales Value (2020-2031)
6.7.2 Europe Riluzole Tablet Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Riluzole Tablet Sales Value (2020-2031)
6.8.2 Asia-Pacific Riluzole Tablet Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Riluzole Tablet Sales Value (2020-2031)
6.9.2 South America Riluzole Tablet Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Riluzole Tablet Sales Value (2020-2031)
6.10.2 Middle East & Africa Riluzole Tablet Sales Value Share by Country, 2024 VS 2031
7 Riluzole Tablet Country-level Sales and Value Analysis
7.1 Global Riluzole Tablet Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Riluzole Tablet Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Riluzole Tablet Sales by Country (2020-2031)
7.3.1 Global Riluzole Tablet Sales by Country (2020-2025)
7.3.2 Global Riluzole Tablet Sales by Country (2026-2031)
7.4 Global Riluzole Tablet Sales Value by Country (2020-2031)
7.4.1 Global Riluzole Tablet Sales Value by Country (2020-2025)
7.4.2 Global Riluzole Tablet Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.5.2 USA Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.6.2 Canada Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.8.2 Germany Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.9.2 France Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.9.3 France Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.11.2 Italy Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.12.2 Spain Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.13.2 Russia Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.16.2 China Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.16.3 China Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.17.2 Japan Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.19.2 India Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.19.3 India Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.20.2 Australia Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.24.2 Chile Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.26.2 Peru Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.28.2 Israel Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.29.2 UAE Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.31.2 Iran Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Riluzole Tablet Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Riluzole Tablet Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Riluzole Tablet Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Apotex
8.1.1 Apotex Comapny Information
8.1.2 Apotex Business Overview
8.1.3 Apotex Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.1.4 Apotex Riluzole Tablet Product Portfolio
8.1.5 Apotex Recent Developments
8.2 Covis Pharma
8.2.1 Covis Pharma Comapny Information
8.2.2 Covis Pharma Business Overview
8.2.3 Covis Pharma Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.2.4 Covis Pharma Riluzole Tablet Product Portfolio
8.2.5 Covis Pharma Recent Developments
8.3 Glemark Generics
8.3.1 Glemark Generics Comapny Information
8.3.2 Glemark Generics Business Overview
8.3.3 Glemark Generics Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.3.4 Glemark Generics Riluzole Tablet Product Portfolio
8.3.5 Glemark Generics Recent Developments
8.4 Italfarmaco
8.4.1 Italfarmaco Comapny Information
8.4.2 Italfarmaco Business Overview
8.4.3 Italfarmaco Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.4.4 Italfarmaco Riluzole Tablet Product Portfolio
8.4.5 Italfarmaco Recent Developments
8.5 Lunan Pharma
8.5.1 Lunan Pharma Comapny Information
8.5.2 Lunan Pharma Business Overview
8.5.3 Lunan Pharma Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.5.4 Lunan Pharma Riluzole Tablet Product Portfolio
8.5.5 Lunan Pharma Recent Developments
8.6 Mylan Pharma
8.6.1 Mylan Pharma Comapny Information
8.6.2 Mylan Pharma Business Overview
8.6.3 Mylan Pharma Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.6.4 Mylan Pharma Riluzole Tablet Product Portfolio
8.6.5 Mylan Pharma Recent Developments
8.7 Sanofi
8.7.1 Sanofi Comapny Information
8.7.2 Sanofi Business Overview
8.7.3 Sanofi Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.7.4 Sanofi Riluzole Tablet Product Portfolio
8.7.5 Sanofi Recent Developments
8.8 Sun Pharma
8.8.1 Sun Pharma Comapny Information
8.8.2 Sun Pharma Business Overview
8.8.3 Sun Pharma Riluzole Tablet Sales, Value and Gross Margin (2020-2025)
8.8.4 Sun Pharma Riluzole Tablet Product Portfolio
8.8.5 Sun Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Riluzole Tablet Value Chain Analysis
9.1.1 Riluzole Tablet Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Riluzole Tablet Sales Mode & Process
9.2 Riluzole Tablet Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Riluzole Tablet Distributors
9.2.3 Riluzole Tablet Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.